| 514 / | HD | DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS |
|
| 1 | DF | DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) {29} |
| 183 | DF | .~ Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI {16} |
| 228.8 | DF | .~.~ Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) {4} |
| 231.2 | DF | .~.~.~ Morpholines (i.e., fully hydrogenated 1,4- oxazines) {5} |
| 231.5 | DF | .~.~.~.~ Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding {3} |
| 232.8 | DF | .~.~.~.~.~ Polycyclo ring system having the additional hetero ring as one of the cyclos {2} |
| 233.5 | DF | .~.~.~.~.~.~ Bicyclo ring system having the additional hetero ring as one of the cyclos {2} |
| 233.8 | DF | .~.~.~.~.~.~.~ Plural ring hetero atoms in the bicyclo ring system {2} |
| 234.5 | DF | .~.~.~.~.~.~.~.~ Plural ring nitrogens in the bicyclo ring system {1} |
| 234.8 |  | .~.~.~.~.~.~.~.~.~ Quinoxalines (including hydrogenated) |